Huapont Life Sciences Co.,Ltd.

XSEC:002004 Stock Report

Market Cap: CN¥8.4b

Huapont Life SciencesLtd Past Earnings Performance

Past criteria checks 3/6

Huapont Life SciencesLtd's earnings have been declining at an average annual rate of -16.3%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 3.7% per year. Huapont Life SciencesLtd's return on equity is 2.4%, and it has net margins of 2.1%.

Key information

-16.3%

Earnings growth rate

-16.1%

EPS growth rate

Chemicals Industry Growth12.1%
Revenue growth rate3.7%
Return on equity2.4%
Net Margin2.1%
Next Earnings Update19 Apr 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Huapont Life SciencesLtd makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

XSEC:002004 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2411,6512492,445395
30 Jun 2411,6482282,467398
31 Mar 2411,5352812,573412
31 Dec 2311,5953022,557419
30 Sep 2311,9042212,621425
30 Jun 2312,4012612,798413
31 Mar 2312,8094422,783403
01 Jan 2313,2324332,911385
30 Sep 2213,9838642,903394
30 Jun 2213,3838752,784348
31 Mar 2213,0117152,811339
01 Jan 2212,4316682,777329
30 Sep 2111,6186582,725308
30 Jun 2111,4466872,690323
31 Mar 2111,4416902,662323
01 Jan 2110,8766522,544324
30 Sep 2010,4856272,746285
30 Jun 2010,2486422,858294
31 Mar 209,8936032,715296
31 Dec 1910,0916202,768288
30 Sep 1910,2145252,792331
30 Jun 1910,5154912,614372
31 Mar 1910,3195102,515339
01 Jan 1910,5745062,403349
30 Sep 1810,9255342,259334
30 Jun 189,9734831,961348
31 Mar 189,8664571,939289
31 Dec 179,1835061,771211
30 Sep 178,2344151,643137
30 Jun 178,0464861,6210
31 Mar 177,6065401,5050
31 Dec 167,0935671,4430
30 Sep 166,4036581,2960
30 Jun 166,1876541,3220
31 Mar 166,1726201,2880
31 Dec 156,1746371,2360
30 Sep 155,8346511,0880
30 Jun 155,5875941,0080
31 Mar 155,2785449140
31 Dec 144,8674298630
30 Sep 145,0384128340
30 Jun 144,9013767450
31 Mar 144,5723146940

Quality Earnings: 002004 has a large one-off loss of CN¥265.1M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 002004's current net profit margins (2.1%) are higher than last year (1.9%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 002004's earnings have declined by 16.3% per year over the past 5 years.

Accelerating Growth: 002004's earnings growth over the past year (12.6%) exceeds its 5-year average (-16.3% per year).

Earnings vs Industry: 002004 earnings growth over the past year (12.6%) exceeded the Chemicals industry -4.7%.

Return on Equity

High ROE: 002004's Return on Equity (2.4%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 09:28
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Huapont Life Sciences Co.,Ltd. is covered by 12 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Peng YanChangjiang Securities Co. LTD.
Pei Hui TangChasing Securities
Bing GaoChina International Capital Corporation Limited